Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps

Yoshimasa Imoto^*, Atsushi Kato, Tetsuji Takabayashi, Whitney Stevens, James E. Norton, Lydia A. Suh, Roderick G. Carter, Ava R. Weibman, Kathryn E. Hulse, Kathleen E. Harris, Anju T. Peters, Leslie C. Grammer, Bruce K. Tan, Kevin Welch, Stephanie Shintani-Smith, David B. Conley, Robert C. Kern, Shigeharu Fujieda, Robert P. Schleimer